Published in Biotech Business Week, January 24th, 2005
The first tranche that has closed amounted to $24.3 million and the second tranche will be $18.3 million upon the completion of certain ongoing development milestones. New investors HBM BioVentures (Cayman) Ltd. and HBM BioCapital LP led the round.
Other new investors include Advent International, InterWest Partners, Genavent Partners (Sanofi-Aventis) and Red Abbey Venture Partners. Investors returning for this fourth financing round include Alta Partners, Forward Ventures, GIMV, Novartis Bioventure Fund, Pacific...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.